Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;42(7):959-964.
doi: 10.1038/s41372-022-01344-2. Epub 2022 Feb 24.

Ampicillin dosing in premature infants for early-onset sepsis: exposure-driven efficacy, safety, and stewardship

Collaborators, Affiliations

Ampicillin dosing in premature infants for early-onset sepsis: exposure-driven efficacy, safety, and stewardship

Jennifer Le et al. J Perinatol. 2022 Jul.

Abstract

Objective: Define optimal ampicillin dosing for empiric early-onset sepsis (EOS) therapy in preterm neonates.

Study design: We simulated ampicillin concentrations in newborns (birthweight < 1500 g; gestational age 22-27 weeks), summarizing three 48 h regimens: high 100 mg/kg Q8hr, medium 100 mg/kg Q12hr, and standard 50 mg/kg Q12hr. Concentration data were analyzed for concentration above minimum inhibitory concentration (MIC), below neurotoxicity threshold (Cmax ≤ 140 mcg/mL), and duration limited to 48 h.

Results: Among 34,689 newborns, all dosing regimens provided concentrations above MIC through 48 h, but Cmax exceeded the neurotoxicity threshold. With the 4-dose standard regimen, >90% maintained concentrations >MIC beyond 48 h. With the 2-dose regimen, newborns maintained the mean concentration >MIC within the 48 h culture window and below neurotoxicity level. Infants 22-24 weeks' gestation had higher drug concentrations and more prolonged exposure duration than 25-27 weeks' gestation.

Conclusions: For EOS in preterm infants, two ampicillin doses (50 mg/kg) provided optimal bactericidal exposures, while minimizing potential toxicity.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: The authors have no relevant conflicts to report.

Figures

Figure 1.
Figure 1.. Probability of therapeutic target attainment over time from therapy initiation
Among VLBW neonates receiving different ampicillin regimens, graphs represent the probability that neonates will reach the desired therapeutic target attainment (PTA) with ampicillin concentration above the MIC for 100% of dosing time interval (fT>MIC =100%) over time from start of therapy and for different MIC breakpoints of 0.25 mcg/mL for GBS, 1 mcg/mL for Streptococcus sp. and Listeria, and 8 mcg/mL for E. coli. Black line represents 90% target attainment. X marks time of doses administered. GBS, group B Streptococcus; hr, hour; MIC, minimum inhibitory concentration; PTA, probability of target attainment; VLBW, very low birth weight
Figure 2.
Figure 2.. Mean predicted concentration versus time curve of ampicillin 50mg/kg/dose.
Mean predicted concentration versus time curve of ampicillin 50mg/kg/dose for 2 (A), and 4 (B) doses for VLBW neonates in two gestational age groups. Concentrations inside the black box are within the concentration metrics, accounting for efficacy (>MIC 1 mcg/mL), safety (≤140 mcg/mL), and stewardship ending at 48-hour culture incubation window. MIC, minimum inhibitory concentration; VLBW, very low birth weight

Similar articles

Cited by

References

    1. Hsieh EM, Hornik CP, Clark RH, Laughon MM, Benjamin DK, Smith PB, et al. Medication use in the neonatal intensive care unit. Am J Perinatol 2014;31:811–21. - PMC - PubMed
    1. Mukhopadhyay S, Puopolo KM. Clinical and microbiologic characteristics of early-onset sepsis among very low birth weight infants: opportunities for antibiotic stewardship. Pediatr Infect Dis J 2017;36:477–81. - PMC - PubMed
    1. Schrag SJ, Farley MM, Petit S, Reingold A, Weston EJ, Pondo T, et al. Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014. Pediatrics. 2016;138:e20162013. - PubMed
    1. Flannery DD, Ross RK, Mukhopadhyay S, Tribble AC, Puopolo KM, Gerber JS. Temporal trends and center variation in early antibiotic use among premature infants. JAMA Netw Open. 2018;1:e180164. - PMC - PubMed
    1. Tremoulet A, Le J, Poindexter B, Sullivan JE, Laughon M, Delmore P, et al. Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study design. Antimicrob Agents Chemother 2014;58:3013–20. - PMC - PubMed

Publication types